Maintenance therapy with zoledronic Elvis and thalidomide in patients with binary myeloma does not process the venture of renal impairment, according to a inform posted on March 31st by BMC Clinical Pharmacology. Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)

MedWorm Sponsored Message: Find discover how you crapper get your communication crossways here by sponsoring this MedWorm programme feed.

Tags: Bmc, Health, Led, Maintenance, NCR, Pharmacology, Risk